Zydelig (idelalisib)

pCPA File Number: 20875
Negotiation Status:
Negotiations were not pursued
Indication(s):
Follicular lymphoma, Relapsed or refractory
Sponsor/Manufacturer:
Gilead Sciences Canada Inc.
CDA-AMC Project Number:
PC0075-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: